Shandong Xinhua Pharmaceutical Yönetim
Yönetim kriter kontrolleri 3/4
Shandong Xinhua Pharmaceutical CEO'su Wenhui Xu, Sep2022 tarihinde atandı, in görev süresi 2.17 yıldır. in toplam yıllık tazminatı CN¥ 1.52M olup, şirket hissesi ve opsiyonları dahil olmak üzere 93.8% maaş ve 6.2% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.035% ine doğrudan sahiptir ve bu hisseler HK$ 3.48M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 4.9 yıl ve 3.9 yıldır.
Anahtar bilgiler
Wenhui Xu
İcra Kurulu Başkanı
CN¥1.5m
Toplam tazminat
| CEO maaş yüzdesi | 93.8% |
| CEO görev süresi | 2.2yrs |
| CEO sahipliği | 0.04% |
| Yönetim ortalama görev süresi | 4.9yrs |
| Yönetim Kurulu ortalama görev süresi | 3.9yrs |
Son yönetim güncellemeleri
Recent updates
Shandong Xinhua Pharmaceutical (HKG:719) Is Paying Out A Larger Dividend Than Last Year
Jun 28
Insufficient Growth At Shandong Xinhua Pharmaceutical Company Limited (HKG:719) Hampers Share Price
Jan 23Shandong Xinhua Pharmaceutical (HKG:719) Takes On Some Risk With Its Use Of Debt
Mar 07Is Shandong Xinhua Pharmaceutical (HKG:719) Using Too Much Debt?
Nov 18These 4 Measures Indicate That Shandong Xinhua Pharmaceutical (HKG:719) Is Using Debt Extensively
Jul 27Shandong Xinhua Pharmaceutical (HKG:719) Has Affirmed Its Dividend Of HK$0.18
Jul 04Estimating The Intrinsic Value Of Shandong Xinhua Pharmaceutical Company Limited (HKG:719)
Mar 09We Think Shandong Xinhua Pharmaceutical (HKG:719) Can Stay On Top Of Its Debt
Dec 21Does Shandong Xinhua Pharmaceutical (HKG:719) Deserve A Spot On Your Watchlist?
Apr 06What Kind Of Shareholders Own Shandong Xinhua Pharmaceutical Company Limited (HKG:719)?
Mar 19Is Shandong Xinhua Pharmaceutical (HKG:719) A Risky Investment?
Feb 26Are Shandong Xinhua Pharmaceutical's (HKG:719) Statutory Earnings A Good Guide To Its Underlying Profitability?
Feb 05
Shandong Xinhua Pharmaceutical (HKG:719) Share Prices Have Dropped 43% In The Last Three Years
Jan 18Is Shandong Xinhua Pharmaceutical Company Limited (HKG:719) A Smart Pick For Income Investors?
Dec 29Do Institutions Own Shandong Xinhua Pharmaceutical Company Limited (HKG:719) Shares?
Dec 14Is Shandong Xinhua Pharmaceutical (HKG:719) Using Too Much Debt?
Nov 26CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | CN¥449m |
| Jun 30 2024 | n/a | n/a | CN¥492m |
| Mar 31 2024 | n/a | n/a | CN¥487m |
| Dec 31 2023 | CN¥2m | CN¥1m | CN¥497m |
| Sep 30 2023 | n/a | n/a | CN¥510m |
| Jun 30 2023 | n/a | n/a | CN¥486m |
| Mar 31 2023 | n/a | n/a | CN¥454m |
| Jan 01 2023 | n/a | n/a | CN¥411m |
| Sep 30 2022 | n/a | n/a | CN¥357m |
| Jun 30 2022 | n/a | n/a | CN¥343m |
| Mar 31 2022 | n/a | n/a | CN¥357m |
| Dec 31 2021 | CN¥1m | n/a | CN¥349m |
| Sep 30 2021 | n/a | n/a | CN¥364m |
| Jun 30 2021 | n/a | n/a | CN¥353m |
| Mar 31 2021 | n/a | n/a | CN¥339m |
| Dec 31 2020 | CN¥829k | n/a | CN¥325m |
Tazminat ve Piyasa: Wenhui 'nin toplam tazminatı ($USD 209.93K ), Hong Kong pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 487.93K ).
Tazminat ve Kazançlar: Wenhui şirketinin tazminatı %20'den fazla artarken, şirketin kazancı geçen yıl %20'den fazla düştü.
CEO
Wenhui Xu (47 yo)
2.2yrs
Görev süresi
CN¥1,521,382
Tazminat
Mr. Wenhui Xu serves as Executive Director and General Manager of Shandong Xinhua Pharmaceutical Company Limited since October 27, 2022 and September 19, 2022 respectively. He served as the Deputy General...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman & Deputy GM | 3.9yrs | CN¥1.61m | 0.043% HK$ 4.2m | |
| GM & Executive Director | 2.2yrs | CN¥1.52m | 0.035% HK$ 3.5m | |
| CFO, Financial Controller & Executive Director | 10.6yrs | CN¥1.28m | 0.048% HK$ 4.7m | |
| Deputy General Manager | 7.7yrs | CN¥1.41m | 0.043% HK$ 4.2m | |
| Deputy GM & Manager of Administrative Personnel Department | no data | CN¥1.41m | 0.035% HK$ 3.5m | |
| Deputy General Manager | 2.2yrs | CN¥831.80k | 0.013% HK$ 1.3m | |
| Company Secretary | 27.3yrs | CN¥446.80k | 0.029% HK$ 2.9m | |
| Deputy General Manager | 2.2yrs | CN¥1.10m | 0.011% HK$ 1.1m | |
| Head of Accounting Department | no data | Veri yok | Veri yok | |
| Chief of Finance Department | no data | Veri yok | Veri yok |
4.9yrs
Ortalama Görev Süresi
51yo
Ortalama Yaş
Deneyimli Yönetim: 719 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.9 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman & Deputy GM | 3.9yrs | CN¥1.61m | 0.043% HK$ 4.2m | |
| GM & Executive Director | 2.1yrs | CN¥1.52m | 0.035% HK$ 3.5m | |
| CFO, Financial Controller & Executive Director | 2.1yrs | CN¥1.28m | 0.048% HK$ 4.7m | |
| Independent Supervisor | 22.4yrs | CN¥24.00k | Veri yok | |
| Non-Executive Director | 14.4yrs | CN¥1.41m | 0.043% HK$ 4.2m | |
| Employee Supervisor | 13.3yrs | CN¥101.00k | Veri yok | |
| Independent Non-Executive Director | 3.9yrs | CN¥100.00k | Veri yok | |
| Chairman of Supervisory Committee | 3.9yrs | Veri yok | Veri yok | |
| Independent Non-Executive Director | 3.9yrs | CN¥100.00k | Veri yok | |
| Independent Non-Executive Director | 2.1yrs | CN¥58.33k | Veri yok | |
| Non-Independent Director | less than a year | Veri yok | Veri yok | |
| Independent Non-Executive Director | less than a year | Veri yok | Veri yok |
3.9yrs
Ortalama Görev Süresi
54yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: 719 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.9 yıldır).